Cancer Chemother Pharmacol
Administration, OralAntineoplastic Combined Chemotherapy ProtocolsCross-Over Studies
Dr. Olivier Rixe, MD
NPI1255568721
- Medicare services, 2022
- 245
- Part D claims, 2022
- 116
- Publications
- 30
- Clinical trials
- 11
- Industry payments
- $2,913
- Practice address
- 933 Bradbury Dr Se, Albuquerque, NM 87106
- Practice phone
- Call (505) 272-4661
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Unm Medical Group - Albuquerque (Bradbury Dr SE)
Multi-specialty group site · Albuquerque, New Mexico
Find Dr. Rixe's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Olivier Rixe is a hematologist and oncologist in Santa Fe, New Mexico
Dr. Rixe practices at Unm Medical Group - Albuquerque (Bradbury Dr SE) in Albuquerque, New Mexico.
Dr. Rixe's NPI, 1255568721, was assigned on June 11, 2009. Dr. Rixe holds New Mexico license MD2016-0632.
NPI and contact details
- NPI
- 1255568721NPI Registry (opens in a new tab)
- NPI enumeration date
- June 11, 2009
- NPI status
- Active
- Practice phone
- (505) 272-4661
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 59
- Medical school graduation
- 1993
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Olivier Rixe practices in Albuquerque and Santa Fe
Dr. Rixe's primary practice is Unm Medical Group - Albuquerque (Bradbury Dr SE), at 933 Bradbury Dr Se, Albuquerque, NM 87106. The practice phone is (505) 272-4661. The NPI Registry lists Dr. Rixe's practice address as 455 St Michaels Dr, Santa Fe, NM 87505.
- Unm Medical Group - Albuquerque (Bradbury Dr SE)Primary933 Bradbury Dr Se, Albuquerque, NM 87106Phone(505) 272-4661
- NPI Registry address455 St Michaels Dr, Santa Fe, NM 87505 · Santa Fe CountyPhone(505) 925-0404
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data
Dr. Olivier Rixe is affiliated with 1 site of care and 1 medical group
Dr. Rixe's primary practice is Unm Medical Group - Albuquerque (Bradbury Dr SE) in Albuquerque, New Mexico. The medical group on file is UNM Medical Group, Inc.
Unm Medical Group - Albuquerque (Bradbury Dr SE)Primary
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. Olivier Rixe's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rixe practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Unm Medical Group - Albuquerque (Bradbury Dr SE) | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Rixe practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Olivier Rixe is one of 69 hematologists and oncologists in New Mexico
Hematology and oncology is Dr. Rixe's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Rixe's licenses on file in 3 states: New Mexico, Georgia and Ohio.
Specialties and state licenses
- Hematology and oncology, New MexicoPrimary
- Georgia license
- Internal medicine, Ohio
Hematologists and oncologists near Dr. Rixe
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Olivier Rixe billed Medicare for 245 services in 2022
CMS data shows 245 Medicare services from Dr. Rixe across 3 procedure codes in 2022. Medicare paid $26,086 for them. Every service was in an office.
Medicare services, 2022245
Paid by Medicare$26,086
Procedure codes3
Dr. Rixe's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Other services
- 2021: 3102022: 14055%
- Office and hospital visits
- 2021: 8662022: 10588%
Dr. Rixe compared with the New Mexico median for hematologists and oncologists, 2022
- Dr. Rixe
- New Mexico median
- Medicare services
- 245vs 48850% below
- Part D claims
- 116vs 30161% below
Medians across 67 hematologists and oncologists in New Mexico with Dmand AI profiles that report each measure.
Dr. Rixe's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rixe?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rixe and other hematologists and oncologists in New Mexico.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Olivier Rixe's patients have a median age of 73
Across all payers, Dmand AI patient panel data puts Dr. Rixe's median patient age at 73, with 60% women.
Dr. Rixe's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women60%
- Men40%
Source: Dmand AI Patient Panel Data
Dr. Olivier Rixe wrote 116 Medicare Part D claims in 2022
In 2022, Dr. Rixe wrote 116 Medicare Part D claims. Every claim was for a generic drug. They cover 5 drugs, with $24,074 in total drug cost. In 2021, CMS named 733 claims across 31 drugs.
Part D claims, 2022116
Drugs named by CMS5
Total drug cost$24,074
Dr. Rixe's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 7332022: 11684%
Drugs named by CMS: 5 in 2022, 31 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Rixe by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Olivier Rixe has 30 publications on record
Dmand AI links 30 papers to Dr. Rixe, published from 2010 to 2020. 2012 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Antibodies, Monoclonal, Humanized. Dr. Rixe has published most often in Clin Cancer Res. Dr. Rixe's most frequent co-authors are Anthony J. Olszanski, MD, Ronald Eugene Warnick, MD and David L. Bajor, MD.
Papers30
Years published2010 to 2020
Dr. Rixe's papers by year, 2010 to 2020
Topics Dr. Rixe writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Antibodies, Monoclonal, Humanized
- Neoplasm Metastasis
- ErbB Receptors
- Angiogenesis Inhibitors
- Axitinib
- Brain Neoplasms
Dr. Rixe's most frequent co-authors
- Anthony J. Olszanski, MD3 shared papers
- Ronald Eugene Warnick, MD3 shared papers
- David L. Bajor, MD2 shared papers
Recent publications by Dr. Rixe
Antineoplastic Combined Chemotherapy ProtocolsCarcinoma, Renal CellCyclophosphamide
See who Dr. Rixe researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rixe works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Olivier Rixe has worked on 11 clinical trials
Dmand AI links Dr. Rixe to 11 clinical trials, 4 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Glioblastoma, Melanoma and Astrocytoma. National Cancer Institute (NCI) sponsors the most, 3. Open Payments lists research payments to Dr. Rixe that name 1 trial.
Clinical trials with Dr. Rixe by phase
- 1Phase 1: 1 trial
- 4Phase 2: 4 trials
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Rixe's trials
- Glioblastoma
- Melanoma
- Astrocytoma
- Nevi and Melanomas
- Gliosarcoma
Investigators on the most trials with Dr. Rixe
- Lynn S. Ashby, MD3 shared trials
- Joanna Amy Kolodney, MD3 shared trials
- Aaron Gerald Mammoser, MD, MS3 shared trials
Recent clinical trials with Dr. Rixe
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma (opens in a new tab)
SuspendedPhase 3
GlioblastomaAstrocytomaICT-107
OBT076, a CD205-directed antibody-drug conjugate
DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma (opens in a new tab)
Active, not recruiting
GliosarcomaGlioblastoma
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma (opens in a new tab)
RecruitingPhase 2/3
MelanomaNevi and MelanomasIpilimumabNivolumabSargramostim
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Olivier Rixe received $2,913 in industry payments from 2016 to 2023
CMS Open Payments shows 110 general payments to Dr. Rixe from 31 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 60% of the total. Pfizer Inc. paid the most, $1,143. It also lists 3 research payments totaling $3,545 from 2016 to 2020, naming 1 clinical trial.
General payments to Dr. Rixe by program year, 2016 to 2023
General payments to Dr. Rixe by kind, 2016 to 2023
$2.9Kin total
- Food and beverage$1,74060%
- Speaker and faculty fees$1,01035%
- Education$1646%
Companies that paid Dr. Rixe the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Olivier Rixe's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Olivier Rixe
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Olivier Rixe's NPI number?
Dr. Olivier Rixe's NPI number is 1255568721. It was assigned on June 11, 2009, and it is active in the NPI Registry.
What kind of doctor is Dr. Olivier Rixe?
Dr. Olivier Rixe is a hematologist and oncologist in Santa Fe, New Mexico. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Olivier Rixe practice?
Dr. Rixe practices at 933 Bradbury Dr Se, Albuquerque, NM 87106. Dr. Rixe also practices at 455 St Michaels Dr, Santa Fe, NM 87505. Dr. Rixe's primary practice is Unm Medical Group - Albuquerque (Bradbury Dr SE) in Albuquerque, New Mexico.
What is Dr. Olivier Rixe's office phone number?
The practice phone on file for Dr. Rixe is (505) 272-4661.
What is Dr. Olivier Rixe's medical license number?
Dr. Rixe holds New Mexico license MD2016-0632, one of the licenses on file in 3 states.
Which states has Dr. Olivier Rixe been licensed in?
Dmand AI has state licenses on file for Dr. Rixe in New Mexico, Georgia and Ohio.
What medical group is Dr. Olivier Rixe part of?
Dr. Rixe is linked to UNM Medical Group, Inc.
Does Dr. Olivier Rixe accept Medicare?
Yes. CMS data shows Dr. Rixe billed Medicare for 245 services in 2022.
What services does Dr. Olivier Rixe bill to Medicare?
In 2022, Dr. Rixe's most billed Medicare services were medicare service (G9678), office visit, established patient (99214) and office visit, established patient (99213).
What drugs does Dr. Olivier Rixe prescribe most?
In 2022 Medicare Part D data, Dr. Rixe's most prescribed drugs by claims were Tamoxifen Citrate, Prednisone and Anastrozole.
Show 4 more questionsShow fewer questions
Has Dr. Olivier Rixe received payments from drug or device companies?
CMS Open Payments shows $2,913 in general payments to Dr. Rixe from 31 companies from 2016 to 2023. The largest total came from Pfizer Inc.
How long has Dr. Olivier Rixe been practicing?
Dr. Rixe graduated from medical school in 1993, 33 years ago.
Does Dr. Olivier Rixe do research?
Dmand AI links 30 publications to Dr. Rixe, published from 2010 to 2020. Dr. Rixe has worked on 11 clinical trials.
Who does Dr. Olivier Rixe publish with?
Dr. Rixe's most frequent co-authors are Anthony J. Olszanski, MD (3 shared papers), Ronald Eugene Warnick, MD (3 shared papers) and David L. Bajor, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in New Mexico by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card